Evofem Biosciences Total Current Liabilities 2011-2026 | EVFM

Annual Total Current Liabilities Evofem Biosciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
84.8 M	80.4 M	72.5 M	93.8 M	138 M	77.3 M	12.7 M	27.3 M	103 M	902 K	9.1 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
138 M	902 K	63.6 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
Adverum Biotechnologies ADVM	22.9 M	-	-	$ 86.2 M	USA
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA
Allakos ALLK	36.6 M	-	-	$ 28.6 M	USA
Akebia Therapeutics AKBA	163 M	$ 1.45	2.84 %	$ 373 M	USA
AlloVir ALVR	9.71 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	15.1 M	-	-	$ 10.1 M	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
Aytu BioScience AYTU	63.1 M	$ 2.63	2.73 %	$ 16.5 M	USA
Applied Therapeutics APLT	71.2 M	-	-	$ 8.42 M	USA
Aravive ARAV	22.1 M	-	-13.39 %	$ 1.45 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
AVROBIO AVRO	6.35 M	-	1083.1 %	$ 745 M	USA
Advaxis ADXS	25 M	-	-9.65 %	$ 45.9 M	USA
Amphastar Pharmaceuticals AMPH	158 M	$ 21.06	0.89 %	$ 984 M	USA
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
Aquestive Therapeutics AQST	47.6 M	$ 4.17	-	$ 446 M	USA
Ayala Pharmaceuticals AYLA	7.54 M	-	-	$ 7.46 M	Israel
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
Arcutis Biotherapeutics ARQT	130 M	$ 24.18	-1.59 %	$ 3.08 B	USA
BeiGene, Ltd. BGNE	1.83 B	-	0.49 %	$ 251 B	Cayman-islands
AgeX Therapeutics AGE	3.56 M	-	-10.17 %	$ 12.2 K	USA
Can-Fite BioPharma Ltd. CANF	2.05 M	$ 2.93	-	$ 6.38 B	Israel
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
CymaBay Therapeutics CBAY	36.8 M	-	-	$ 3.45 B	USA
AIkido Pharma AIKI	1.61 M	-	1.93 %	$ 17.4 M	USA
Cabaletta Bio CABA	50.2 M	$ 3.12	-1.58 %	$ 313 M	USA
Codiak BioSciences CDAK	27.2 M	-	-55.98 %	$ 2.15 M	USA
Aptose Biosciences APTO	9.31 M	-	-45.71 %	$ 1.2 M	Canada
Avid Bioservices CDMO	70.6 M	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	49.6 M	-	-	$ 1.41 B	USA
Celldex Therapeutics CLDX	51 M	$ 33.37	-0.74 %	$ 2.22 B	USA
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA
Checkpoint Therapeutics CKPT	20.1 M	-	-	$ 169 M	USA
Concert Pharmaceuticals CNCE	16.1 M	-	-	$ 401 M	USA
Akari Therapeutics, Plc AKTX	12.4 M	$ 3.8	-3.06 %	$ 256 B	Britain
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA
Celsion Corporation CLSN	4.62 M	-	-6.63 %	$ 13.9 M	USA
Allena Pharmaceuticals ALNA	15.7 M	-	3.16 %	$ 1.9 M	USA
Checkmate Pharmaceuticals CMPI	9.38 M	-	-	$ 231 M	USA